TMO:NYE-Thermo Fisher Scientific Inc (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 525.29

Change

+1.24 (+0.24)%

Market Cap

USD 56.05B

Volume

1.56M

Analyst Target

USD 451.22
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Thermo Fisher Scientific Inc offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-23 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

+0.61 (+0.27%)

USD 165.08B
A Agilent Technologies Inc

+0.09 (+0.07%)

USD 40.09B
IQV IQVIA Holdings Inc

+1.84 (+0.93%)

USD 36.13B
LH Laboratory Corporation of Amer..

-0.77 (-0.34%)

USD 19.12B
DGX Quest Diagnostics Incorporated

-0.16 (-0.10%)

USD 17.09B
QGEN Qiagen NV

+0.15 (+0.34%)

USD 10.26B
CRL Charles River Laboratories

-0.38 (-0.20%)

USD 9.50B
VNRX Volitionrx Ltd

-0.07 (-9.75%)

USD 0.06B
ENZ Enzo Biochem Inc

-0.02 (-2.85%)

USD 0.04B
MTD Mettler-Toledo International I..

+3.65 (+0.30%)

N/A

ETFs Containing TMO

XDNA 9.55 % 0.00 %

N/A

N/A
SYNB Putnam Biorevolution ETF 6.68 % 0.00 %

+0.26 (+1.59%)

USD 5.36M
LIFE-U:CA Evolve Global Healthcare .. 5.51 % 0.00 %

+0.12 (+1.59%)

N/A
THNR Amplify ETF Trust 4.94 % 0.00 %

+0.36 (+1.59%)

USD 4.36M
DXSI:XETRA Xtrackers - Stoxx Europe .. 4.55 % 0.00 %

+0.26 (+1.59%)

USD 0.02B
AILG 4.51 % 0.00 %

N/A

N/A
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.38 % 0.00 %

-0.02 (1.59%)

USD 0.14B
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.34 % 0.00 %

-0.14 (1.59%)

N/A
XGES:LSE Xtrackers MSCI Genomic He.. 4.10 % 0.00 %

-0.01 (1.59%)

N/A
XSPD:LSE Xtrackers - S&P 500 Inver.. 4.09 % 0.00 %

+0.02 (+1.59%)

USD 0.10B
XSPS:LSE Xtrackers S&P 500 Inverse.. 4.09 % 0.00 %

+4.85 (+1.59%)

USD 0.10B
MHCD:CA Middlefield Healthcare Di.. 4.05 % 0.00 %

+0.06 (+1.59%)

CAD 0.16B
XUHC:SW 4.03 % 0.00 %

N/A

N/A
QDVG:XETRA iShares S&P 500 Health Ca.. 3.95 % 0.00 %

-0.05 (1.59%)

USD 2.05B
XLV Health Care Select Sector.. 3.92 % 0.13 %

+0.75 (+1.59%)

USD 36.67B
IUHC:SW iShares S&P 500 Health Ca.. 3.92 % 0.00 %

+0.12 (+1.59%)

N/A
GXLV:LSE SPDR® S&P® U.S. Health .. 3.92 % 0.00 %

-0.05 (1.59%)

N/A
WH2E:XETRA Invesco S&P World Health .. 3.83 % 0.00 %

N/A

USD 0.06B
SXLV:SW SPDR S&P U.S. Health Care.. 3.75 % 0.00 %

+0.07 (+1.59%)

N/A
ZPDH:F SPDR S&P U.S. Health Care.. 3.74 % 0.00 %

+0.06 (+1.59%)

USD 0.40B
ZPDH:XETRA SPDR S&P U.S. Health Care.. 3.74 % 0.00 %

-0.19 (1.59%)

USD 0.40B
XSHC:LSE Xtrackers MSCI USA Health.. 3.74 % 0.00 %

-3.50 (1.59%)

USD 0.61B
XUHC:LSE Xtrackers MSCI USA Health.. 3.74 % 0.00 %

-0.38 (1.59%)

USD 0.61B
XUHC:F Xtrackers (IE) Public Lim.. 3.62 % 0.00 %

+0.55 (+1.59%)

USD 0.85B
XUHC:XETRA Xtrackers MSCI USA Health.. 3.62 % 0.00 %

-0.23 (1.59%)

USD 0.85B
DRUG:AU BetaShares Global Healthc.. 3.57 % 0.00 %

+0.04 (+1.59%)

USD 0.17B
CURE Direxion Daily Healthcare.. 3.49 % 1.06 %

+2.58 (+1.59%)

USD 0.17B
FHLC Fidelity® MSCI Health Ca.. 3.38 % 0.08 %

+0.65 (+1.59%)

USD 2.62B
HEAW:LSE SPDR® MSCI World Health .. 2.71 % 0.00 %

+0.18 (+1.59%)

N/A
XWHS:LSE Xtrackers MSCI World Heal.. 2.68 % 0.00 %

+0.11 (+1.59%)

USD 2.54B
ABIE:XETRA AXA IM ACT Biodiversity E.. 2.62 % 0.00 %

-0.08 (1.59%)

N/A
ABIT:XETRA AXA IM ACT Biodiversity E.. 2.44 % 0.00 %

-0.06 (1.59%)

N/A
ABIT:F AXA IM ACT Biodiversity E.. 2.27 % 0.00 %

+0.10 (+1.59%)

N/A
ABIE:F AXA IM ACT Biodiversity E.. 2.27 % 0.00 %

N/A

N/A
PFUT Putnam Sustainable Future.. 1.88 % 0.00 %

N/A

USD 0.35B
HYLG Global X Funds - Global X.. 1.84 % 0.00 %

+0.15 (+1.59%)

N/A
TDVG T. Rowe Price Dividend Gr.. 1.51 % 0.00 %

-0.07 (1.59%)

USD 0.83B
JPST JPMorgan Ultra-Short Inco.. 0.74 % 0.00 %

N/A

USD 28.13B
IBLN 0.00 % 0.64 %

N/A

N/A
IXJ iShares Global Healthcare.. 0.00 % 0.46 %

+0.87 (+1.59%)

N/A
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

+0.51 (+1.59%)

N/A
JHMH 0.00 % 0.46 %

N/A

N/A
LDUR PIMCO Enhanced Low Durati.. 0.00 % 1.02 %

-0.12 (1.59%)

USD 0.85B
JMIN 0.00 % 0.12 %

N/A

N/A
ACT Enact Holdings Inc 0.00 % 0.75 %

-0.20 (1.59%)

USD 5.03B
PVAL Putnam Focused Large Cap .. 0.00 % 0.29 %

+0.14 (+1.59%)

USD 1.59B
KORP American Century Diversif.. 0.00 % 0.45 %

-0.10 (1.59%)

USD 0.38B
LS:CA 0.00 % 2.21 %

N/A

N/A
HWF:CA 0.00 % 0.00 %

N/A

N/A
CGAA:CA CI Global Asset Allocatio.. 0.00 % 0.00 %

-0.01 (1.59%)

CAD 0.03B
HHL-U:CA Harvest Healthcare Leader.. 0.00 % 0.00 %

+0.03 (+1.59%)

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

-0.22 (1.59%)

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

-0.22 (1.59%)

N/A
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

+0.83 (+1.59%)

N/A
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

+2.30 (+1.59%)

N/A
XHC:CA iShares Global Healthcare.. 0.00 % 0.65 %

+0.61 (+1.59%)

CAD 0.54B
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

-0.50 (1.59%)

N/A
IUHC:LSE iShares S&P 500 USD Healt.. 0.00 % 0.00 %

-0.06 (1.59%)

USD 2.50B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

-0.27 (1.59%)

N/A
WHEA:LSE SPDR® MSCI World Health .. 0.00 % 0.00 %

-0.16 (1.59%)

N/A
XDWH:LSE Xtrackers MSCI World Heal.. 0.00 % 0.00 %

-0.11 (1.59%)

N/A
XFVT:LSE Xtrackers FTSE Vietnam Sw.. 0.00 % 0.00 %

-5.00 (1.59%)

N/A
QDVG:F iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+0.12 (+1.59%)

N/A
HIG-U:CA 0.00 % 0.00 %

N/A

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
IXJ:AU iShares Global Healthcare.. 0.00 % 0.00 %

+0.10 (+1.59%)

USD 1.45B
DWEQ 0.00 % 0.00 %

N/A

N/A
HHL-B:CA Harvest Healthcare Leader.. 0.00 % 0.00 %

+0.04 (+1.59%)

N/A
SROI Calamos Antetokounmpo Glo.. 0.00 % 0.00 %

N/A

N/A
CFCV 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.04% 46% F 35% F
Dividend Return 0.29% 29% F 3% F
Total Return -0.74% 46% F 25% F
Trailing 12 Months  
Capital Gain -0.71% 46% F 35% F
Dividend Return 0.29% 29% F 3% F
Total Return -0.42% 46% F 25% F
Trailing 5 Years  
Capital Gain 60.88% 92% A 78% C+
Dividend Return 1.86% 20% F 5% F
Total Return 62.74% 92% A 75% C
Average Annual (5 Year Horizon)  
Capital Gain 12.55% 54% F 70% C-
Dividend Return 12.75% 54% F 66% D+
Total Return 0.20% 29% F 7% C-
Risk Return Profile  
Volatility (Standard Deviation) 19.78% 85% B 55% F
Risk Adjusted Return 64.45% 100% F 78% C+
Market Capitalization 56.05B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.